Skip to main content
Bilal Murad, MD, Cardiology, Saint Paul, MN

Bilal Mahmood Murad MD

Adult Congenital Heart Disease, Interventional Cardiology, Cardiac Critical Care


Interventional Cardiologist, Minneapolis Heart Institute at United. Director of Interventional Cardiology & Cardiac Catheterization Laboratory, United Hospital, St. Paul MN

Join to View Full Profile
  • 225 Smith Ave NSte 400Saint Paul, MN 55102

  • Phone+1 651-290-0133

  • Fax+1 651-241-2910

Dr. Murad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Michigan
    University of MichiganFellowship, Interventional Cardiology, 1999 - 2000
  • University of Minnesota
    University of MinnesotaFellowship, Cardiovascular Disease, 1996 - 1999
  • Hennepin Healthcare
    Hennepin HealthcareResidency, Internal Medicine, 1993 - 1996
  • Aga Khan Medical College
    Aga Khan Medical CollegeClass of 1991

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1995 - 2025
  • WI State Medical License
    WI State Medical License 2005 - 2025
  • MI State Medical License
    MI State Medical License 1999 - 2000
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Interventional Cardiology
    American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Minneapolis Heart Institute Foundation Launches the PROGRESS Clinical Trial to Examine the Safety and Effectiveness of Transcatheter Valve Replacement in Patients with Moderate, Calcific Aortic Stenosis
    Minneapolis Heart Institute Foundation Launches the PROGRESS Clinical Trial to Examine the Safety and Effectiveness of Transcatheter Valve Replacement in Patients with Moderate, Calcific Aortic StenosisSeptember 21st, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: